Clinical trials get under way in Oxford for new Ebola vaccine

The video discusses a new Ebola vaccine trial at the Jenner Institute, using technology from the Oxford AstraZeneca COVID vaccine. It targets two Ebola virus species responsible for most outbreaks. The trial begins with a low dose for safety, and volunteers are recruited through the Jenner Institute website. The video also highlights other vaccine research at Oxford, including Rift Valley Fever and plague vaccines.

What technology is being used to develop the new Ebola vaccine at the Jenner Institute?

• The same technology used for the Oxford AstraZeneca COVID vaccine

• Traditional inactivated virus technology

• mRNA technology

• CRISPR technology

Which two species of Ebola virus does the new vaccine target?

• Bundibugyo ebolavirus and Tai Forest ebolavirus

• Sudan ebolavirus and Zaire ebolavirus

• Reston ebolavirus and Bundibugyo ebolavirus

• Zaire ebolavirus and Reston ebolavirus

What percentage of the final dose was given to the first volunteer in the Ebola vaccine trial?

• 5%

• 50%

• 10%

• 20%

What is the Jenner Institute's approach to expanding the Ebola vaccine trial?

• Gradually increasing the dose and number of volunteers

• Using only animal models

• Conducting trials only in Oxford

• Administering the full dose immediately

Which emerging disease is the Jenner Institute developing a vaccine for, besides Ebola?

• Zika virus

• Rift Valley Fever virus

• Chikungunya virus

• Dengue fever